|
Integrated Diagnostics Holdings PLC on Tuesday reported ‘strong’ first-half growth and declared a dividend, as higher volumes and pricing lifted margins across its network. The diagnostic services provider with operations in Egypt, Jordan, Nigeria, Sudan and Saudi Arabia, said revenue for the six months to June 30 rose 42% year-on-year to EGP3.54 billion, around $74.34 million, from EGP2.50 billion. Net profit increased 19% to EGP571 million from EGP480 million. IDH declared a cash dividend of $0.017 per share, totalling $10 million, in respect of the year ended Dec 31, 2024. Margins improved ‘across the board’, with gross profit jumping 61% to EGP1.49 billion, and gross margin up five percentage points to 42%. Adjusted earnings before interest, tax, depreciation and amortisation climbed 78% to EGP1.19 billion, lifting the margin to around 34% from 27%. Excluding foreign-exchange gains in both periods, normalised net profit more than doubled to EGP575 million, with a margin of 16% versus 7.3% a year earlier. Second-quarter revenue rose 48% to EGP1.96 billion, with adjusted Ebitda more than doubling to EGP691 million, and net profit up to EGP326 million from EGP78 million. Activity was supported by a 10% increase in tests performed to 19.6 million and a 29% rise in average revenue per test. The branch network expanded to 678 sites, up 87 year-on-year. IDH also said its Egyptian radiology arm, Al Borg Scan, completed the acquisition of Cairo Ray for Radiotherapy in east Cairo for EGP400 million late in the second quarter, advancing its plan to build a broader radiology offering alongside pathology. Chief Executive Officer Hend El-Sherbini said IDH expects full-year revenue growth ‘above 30%’ in 2025 and an Ebitda margin ‘north of 30%.’ Shares in Integrated Diagnostics rose 5.2% to $0.51 in London on Tuesday morning. Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
